• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume9, Issue1

TO COMPARE THE PLATELET-RICHPLASMA THERAPY AND CORTICOSTEROID INJECTION IN THEMANAGEMENT OF PLANTER FASCIITIS

    Dr Sumit Pal Singh, Dr Pallav Gupta, Dr Nitish Sharma, Dr Anil Gupta, Dr Manmeet Singh

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 1620-1626

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim:To compare the platelet-rich plasma therapy and corticosteroid injection in themanagement of planter fasciitis.
Methods: The prospective clinical trial was carried out at the Department of Orthopaedics. The research involved 40 patients who were randomly assigned to one of two groups: PRP (n=20) or Steroid (n=20). 25-27 ml of blood was taken from the cubital vein and deposited in a glass tube with 3 ml of citrate dextrose solution to make platelet-rich plasma (ratio 9:1). To avoid clotting, a citrate dextrose solution was utilised. For 10-13 minutes, the blood was centrifuged at 3300 rpm. The top buffy coat yielded 3ml of PRP preparation.
Results: In the steroid and PRP groups, the mean initial or pre injection VAS and AOFAS scores were 8.1±1.9, 60.37±9.58 and 8.9±2.6, 62.57±9.87, respectively, and were similar (0.15 and 0.22). Following injection, the score improved significantly in each group at each follow-up; however, no significant difference could be detected between the two groups at the 1 VAS (4.4±2.5 vs 3.5±0.88), AOFAS (79.89±9.74 vs 81.11±8.74), 3 VAS (2.6±0. 21 VS 2.1±0.78), AOFAS (84.15±10.55 VS 86.99±10.67) and 6-month VAS (2.1±0.85 VS 1.6±0.45, AOFA.
Conclusion: We found that steroid or PRP injection therapy for plantar fasciitis is equally effective.
Keywords:
    Platelet-richplasma Corticosteroid injection management Planter fasciitis
  • PDF (165 K)
  • XML
(2022). TO COMPARE THE PLATELET-RICHPLASMA THERAPY AND CORTICOSTEROID INJECTION IN THEMANAGEMENT OF PLANTER FASCIITIS. European Journal of Molecular & Clinical Medicine, 9(1), 1620-1626.
Dr Sumit Pal Singh, Dr Pallav Gupta, Dr Nitish Sharma, Dr Anil Gupta, Dr Manmeet Singh. "TO COMPARE THE PLATELET-RICHPLASMA THERAPY AND CORTICOSTEROID INJECTION IN THEMANAGEMENT OF PLANTER FASCIITIS". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 1620-1626.
(2022). 'TO COMPARE THE PLATELET-RICHPLASMA THERAPY AND CORTICOSTEROID INJECTION IN THEMANAGEMENT OF PLANTER FASCIITIS', European Journal of Molecular & Clinical Medicine, 9(1), pp. 1620-1626.
TO COMPARE THE PLATELET-RICHPLASMA THERAPY AND CORTICOSTEROID INJECTION IN THEMANAGEMENT OF PLANTER FASCIITIS. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 1620-1626.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 45
  • PDF Download: 92
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus